User profiles for David R. Carr

David R. Carr, MD MPH

Associate Professor of Dermatology
Verified email at osumc.edu
Cited by 641

An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action

DSJ Pang, CJ Robledo, DR Carr… - Proceedings of the …, 2009 - National Acad Sciences
TASK channels are acid-sensitive and anesthetic-activated members of the family of two-pore-domain
potassium channels. We have made the surprising discovery that the genetic …

GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep–wake switch or propofol-induced loss of consciousness

AY Zecharia, X Yu, T Götz, Z Ye, DR Carr… - Journal of …, 2012 - Soc Neuroscience
The activity of histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus
correlates with an animal's behavioral state and maintains arousal. We examined how …

Gene therapies: the challenge of super-high-cost treatments and how to pay for them

DR Carr, SE Bradshaw - Regenerative medicine, 2016 - Future Medicine
Gene therapies have the potential to cure rare conditions that often have no current efficacious
treatments with a one-time treatment episode, relieving substantial unmet need and …

Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity

TM COFFMAN, DR CARR, WE YARGER… - …, 1987 - journals.lww.com
EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION... :
Transplantation EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE …

Controlling the butchers in late medieval English towns

DR Carr - The Historian, 2008 - Taylor & Francis
Contrary to popular belief, medieval municipal populations and governments took pains to
improve their urban environments. Their efforts frequently focused on controlling the impact of …

Off‐label uses of rituximab in dermatology

DR Carr, MP Heffernan - Dermatologic Therapy, 2007 - Wiley Online Library
Since its approval in 1997 by the FDA, rituximab has been approved for use in certain B‐cell
lymphomas and treatment‐resistant rheumatoid arthritis. Over the past 10 years, many case …

Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma: appropriate patient selection and perspectives

L Mager, S Gardeen, DR Carr… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Five percent of patients with cutaneous squamous cell carcinoma develop locally advanced
or metastatic disease that is not amenable to definitive surgical or radiation therapy. …

[HTML][HTML] Programmed evolution for optimization of orthogonal metabolic output in bacteria

…, SA Callen, JS Campbell, CJ Carr, DR Carr… - PLoS …, 2015 - journals.plos.org
Current use of microbes for metabolic engineering suffers from loss of metabolic output due
to natural selection. Rather than combat the evolution of bacterial populations, we chose to …

[HTML][HTML] Definition, association with malignancy, biologic behavior, and treatment of ectopic extramammary Paget's disease: A review of the literature

CA Scarbrough, A Vrable, DR Carr - The Journal of clinical and …, 2019 - ncbi.nlm.nih.gov
Background: Extramammary Paget’s disease (EMPD) is a rare neoplasm that affects
apocrine gland-bearing skin. Patients usually present with a long-standing, unilateral, ill-defined, …

Metastatic spiradenocarcinoma managed with PD-1 inhibition

JJ Wargo, DR Carr, JA Plaza… - Journal of the National …, 2022 - jnccn.org
Spiradenomas are rare skin adnexal tumors, usually benign, appearing in early adulthood.
The etiology of this tumor is still debated. The tumor suppressor gene CYLD , responsible for …